129 related articles for article (PubMed ID: 36988385)
1. MRI of Peliosis Hepatis: A Case Series Presentation With a 2022 Systematic Literature Update.
Calistri L; Nardi C; Rastrelli V; Maraghelli D; Grazioli L; Messerini L; Colagrande S
J Magn Reson Imaging; 2023 Nov; 58(5):1386-1405. PubMed ID: 36988385
[TBL] [Abstract][Full Text] [Related]
2. Focal peliosis hepatis as a mimicker of hepatic tumors: radiological-pathological correlation.
Kim SH; Lee JM; Kim WH; Han JK; Lee JY; Choi BI
J Comput Assist Tomogr; 2007; 31(1):79-85. PubMed ID: 17259837
[TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance imaging and diffusion weighted imaging features of focal peliosis hepatis].
Liu ZJ; Yao JM; Wang ML; Geng TT; Dong G; Zeng MS
Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(7):496-499. PubMed ID: 30786345
[No Abstract] [Full Text] [Related]
4. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
Kim SS; Kim SH; Song KD; Choi SY; Heo NH
J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
6. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
[TBL] [Abstract][Full Text] [Related]
7. Imaging features of hepatic inflammatory pseudotumor: distinction from colorectal liver metastasis using gadoxetate disodium-enhanced magnetic resonance imaging.
Ichikawa S; Motosugi U; Suzuki T; Shimizu T; Onishi H
Abdom Radiol (NY); 2020 Aug; 45(8):2400-2408. PubMed ID: 32468212
[TBL] [Abstract][Full Text] [Related]
8. Contrast enhanced ultrasound of a rare case of Peliosis hepatis.
Loizides A; Glodny B; Zoller H; Zelger BG; Junker D; Henninger B; Putzer D; Gruber H
Med Ultrason; 2017 Jan; 19(1):114-116. PubMed ID: 28180205
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of inflammatory pseudotumor of the liver: a 2021 systematic literature update and series presentation.
Calistri L; Maraghelli D; Nardi C; Vidali S; Rastrelli V; Crocetti L; Grazioli L; Colagrande S
Abdom Radiol (NY); 2022 Aug; 47(8):2795-2810. PubMed ID: 35648207
[TBL] [Abstract][Full Text] [Related]
10. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
11. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
Lebert P; Adens-Fauquembergue M; Azahaf M; Gnemmi V; Behal H; Luciani A; Ernst O
Eur Radiol; 2019 Nov; 29(11):5742-5751. PubMed ID: 30993437
[TBL] [Abstract][Full Text] [Related]
12. Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI.
Chou CT; Chen RC; Chen WT; Lii JM
J Chin Med Assoc; 2011 Feb; 74(2):62-8. PubMed ID: 21354082
[TBL] [Abstract][Full Text] [Related]
13. Peliosis Hepatis Mimicking Malignant Hypervascular Tumors.
Iwata T; Adachi K; Takahashi M
J Gastrointest Surg; 2017 Jun; 21(6):1095-1098. PubMed ID: 27783341
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid.
Besa C; Lewis S; Pandharipande PV; Chhatwal J; Kamath A; Cooper N; Knight-Greenfield A; Babb JS; Boffetta P; Padron N; Sirlin CB; Taouli B
Abdom Radiol (NY); 2017 Jan; 42(1):179-190. PubMed ID: 27448609
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
[TBL] [Abstract][Full Text] [Related]
16. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.
Korpraphong P; Leyendecker JR; Hildebolt CF; Narra V; Bae KT; Brown JJ
J Med Assoc Thai; 2009 Apr; 92(4):548-55. PubMed ID: 19374308
[TBL] [Abstract][Full Text] [Related]
17. Unusual cross-sectional imaging findings in hepatic peliosis.
Steinke K; Terraciano L; Wiesner W
Eur Radiol; 2003 Aug; 13(8):1916-9. PubMed ID: 12942295
[TBL] [Abstract][Full Text] [Related]
18. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.
Phongkitkarun S; Limsamutpetch K; Tannaphai P; Jatchavala J
World J Gastroenterol; 2013 Dec; 19(45):8357-65. PubMed ID: 24363528
[TBL] [Abstract][Full Text] [Related]
19. Lipiodol accumulation in focal peliosis hepatis with sinusoidal dilatation.
Shim SG; Paik SW; Hyun JG; Choi MS; Lee JH; Rhee PL; Kim JJ; Koh KC; Rhee JC; Choi KW; Park CK
J Clin Gastroenterol; 2001 Apr; 32(4):356-8. PubMed ID: 11276285
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric magnetic resonance imaging features of giant intracranial tuberculomas.
Peer S; Tiwari S; Swaminathan AD; Jabeen S; Saini J; Prasad C; Kulanthaivelu K; Murumkar V; Vengalil S; Netravathi M; Nalini A; Raju S; Swaroop NS; Srinivas D
Clin Neurol Neurosurg; 2021 Nov; 210():107006. PubMed ID: 34739879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
